(Q46048168)

19 December 2017

title

MUSE therapy: preliminary clinical observations (English)

1 reference

19 December 2017

author name string

Werthman P

series ordinal

1

1 reference

19 December 2017

Rajfer J

series ordinal

2

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

19 December 2017

published in

Urology

1 reference

19 December 2017

volume

50

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

809-811

1 reference

19 December 2017

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900448-2

7 January 2021

Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900448-2

7 January 2021

High attrition rate with intracavernous injection of prostaglandin E1 for impotency

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900448-2

7 January 2021

Predictors of success and risk factors for attrition in the use of intracavernous injection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900448-2

7 January 2021

Intraurethral prostaglandin E-2 cream: a possible alternative treatment for erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900448-2

7 January 2021

Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900448-2

7 January 2021

A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900448-2

7 January 2021

Intracavernous injection of prostaglandin E1 for the treatment of erectile impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900448-2

7 January 2021

Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900448-2

7 January 2021

Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900448-2

7 January 2021

10.1016/S0090-4295(97)00448-2

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017